A single quarter of synchronized passive trimming is NOT a negative catalyst by itself—index rebalancing rules and tax-loss harvesting are the more likely explanations for this pattern. However, the absence of any active-fund buyers in Q3 is an adverse contrast to the 30-day insider-buying cluster ($122K in aggregate). Traders should cross-reference the next 13F filing for a reversal; if active funds also continue selling, the bearish signal strengthens. The 82% Street consensus on RCEL is overwhelmingly bullish—a passive-unwind backstop against a crowded long thesis is a tactical risk.
Executive Summary
Five passive mega-managers—BlackRock, Morgan Stanley, Schwab, Wells Fargo, and Fidelity—uniformly trimmed their AVITA Medical (RCEL) stakes in Q3 2025, with aggregate net selling of ~$5.2M against a $127M market cap. The consensus trim is suspiciously synchronized and material relative to the float, but because these are exclusively passive/quant funds, the signal likely reflects index rebalancing or a liquidity calibration rather than a fundamental thesis shift.
Key Financial Metrics
Institutional Positions
Net institutional flow: -$5.2M
▼ Sellers (5)
| Institution | Action | Change | Prev Value | Value Δ |
|---|---|---|---|---|
| BlackRock | TRIM | -39.9% | $10.5M | -$4.2M |
| Fidelity | TRIM | -38.1% | $24.4K | -$9.7K |
| Morgan Stanley | TRIM | -56.2% | $1.2M | -$678.5K |
| Wells Fargo | TRIM | -39.7% | $82.7K | -$34.7K |
| Schwab | TRIM | -46.8% | $452.6K | -$220.8K |
Key Facts
- 5 passive institutions trimmed RCEL in Q3 2025; 0 buyers recorded
- Total net institutional selling: ~$5.15M (~4% of market cap)
- BlackRock alone cut 757K shares (−39.9%), value drop from $10.0M to $5.8M
- Morgan Stanley cut 125K shares (−56.2%), value from $1.2M to $497K
- Schwab cut 40K shares (−46.8%), value from $454K to $233K
- Fidelity and Wells Fargo cuts were smaller in dollar terms but same direction
- No active-fund, activist, or family-office buyers appeared to offset the selling
Financial Impact
~$5.15M in aggregate institutional selling, representing roughly 4% of the $127M market cap being sold by passive holders in a single quarter
Risk Factors
- The selling is 100% passive—may reflect index reconstitution, not fundamental deterioration
- Active money may have been buying off-quarter; 13F data is 45 days stale
- No short disclosure in 13F—the cluster signal is one-sided and incomplete
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-RCEL-2025-Q3 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 20, 2026 5d ago | Press Release | $15.29 | awaiting T+60 | — | — |
Sep 22, 2026 4w ago | Institutional Cluster | $11.49 | awaiting T+60 | — | — |
Aug 9, 2026 11w ago | Press Release | $7.60 | awaiting T+60 | — | — |
Jun 11, 2026 19w ago | Institutional Cluster | $3.97 $11.20 | ▼ −182.12% | ▼ −177.72% | — |
May 17, 2026 23w ago | Press Release | $4.19 | awaiting T+60 | — | — |
Apr 30, 2026 25w ago | Press Release | $4.32 $4.75 | ▲ +9.95% | ▲ +6.85% | — |
Apr 23, 2026 26w ago | Press Release | $4.46 $5.09 | ▲ +14.13% | ▲ +9.05% | — |
Apr 14, 2026 27w ago | Press Release | $5.60 $4.41 | ▼ −21.25% | ▼ −29.77% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers